Preferential binding of monocytes and Leu 2+ T lymphocytes to interferon-gamma treated cultured skin endothelial cells and keratinocytes - PubMed (original) (raw)
Preferential binding of monocytes and Leu 2+ T lymphocytes to interferon-gamma treated cultured skin endothelial cells and keratinocytes
B J Nickoloff et al. Arch Dermatol Res. 1988.
Free article
Abstract
Recombinant gamma interferon (r-IFN-gamma) increases the adherence of peripheral blood mononuclear leukocytes (PBMLs) to cultured keratinocytes and cutaneous microvascular endothelial cells (MECs). To determine which specific type of PBMLs bound to these r-IFN-gamma treated cells, we performed immunophenotyping on the adherent PBMLs. The adherent PBMLs were detached from the r-IFN-gamma treated keratinocytes and MECs by adding EDTA, and collected by cytocentrifugation, followed by immunocytochemical staining using a panel of monoclonal antibodies. Our results reveal that the relative adherent population of PBMLs was composed of approximately 60%-70% monocytes and 18%-24% Leu 2+ T lymphocytes (T-cytotoxic/suppressor) which preferentially bound to r-IFN-gamma treated keratinocytes and MECs. There was some lesser binding by Leu 3 + lymphocytes (T-helper/inducer); approximately 8%, and no binding of B lymphocytes. Since r-IFN-gamma also induced HLA-DR expression in keratinocytes and MECs, these in vitro data suggest that r-IFN-gamma may play an important role in the immunobiology of diverse skin diseases such as graft vs host disease, lichen planus, and other inflammatory dermatoses, because the keratinocytes express HLA-DR and the predominant T-cell subset in the epidermis is Leu 2 + (over the Leu 3 + T cell) in all of these conditions. These results represent a direct attempt to explain in situ immunophenotypic mononuclear leukocyte subset distribution patterns by using r-IFN-gamma and purified cultured cells such as keratinocytes and MECs. We propose that IFN-gamma, by both increasing the adherence of PBMLs, and promoting selective binding of monocytes and Leu 2 + T lymphocytes to both keratinocytes and MECs, may be important in regulating PBML localization and recirculation in the skin.
Similar articles
- Enhanced binding of peripheral blood mononuclear leukocytes to gamma-interferon-treated cultured keratinocytes.
Nickoloff BJ, Lewinsohn DM, Butcher EC. Nickoloff BJ, et al. Am J Dermatopathol. 1987 Oct;9(5):413-8. doi: 10.1097/00000372-198710000-00007. Am J Dermatopathol. 1987. PMID: 2446518 - T lymphocytes and monocytes bind to keratinocytes in frozen sections of biopsy specimens of normal skin treated with gamma interferon.
Nickoloff BJ, Griffiths CE. Nickoloff BJ, et al. J Am Acad Dermatol. 1989 May;20(5 Pt 1):736-43. doi: 10.1016/s0190-9622(89)70083-9. J Am Acad Dermatol. 1989. PMID: 2497158 - [How does eczema arise?].
Trautmann A, Disch R, Bröcker EB, Akdis CA, Gillitzer R. Trautmann A, et al. J Dtsch Dermatol Ges. 2003 Jan;1(1):8-11. doi: 10.1046/j.1610-0387.2003.t01-1-02020.x. J Dtsch Dermatol Ges. 2003. PMID: 16285287 Review. German.
Cited by
- The Measurement of Serum Tumor Necrosis Factor-alpha Levels in Patients with Lichen Planus.
Kara YA. Kara YA. Indian J Dermatol. 2018 Jul-Aug;63(4):297-300. doi: 10.4103/ijd.IJD_474_17. Indian J Dermatol. 2018. PMID: 30078872 Free PMC article. Retracted. - Characterization and functional analysis of the expression of intercellular adhesion molecule-1 in human papillomavirus-related disease of cervical keratinocytes.
Coleman N, Greenfield IM, Hare J, Kruger-Gray H, Chain BM, Stanley MA. Coleman N, et al. Am J Pathol. 1993 Aug;143(2):355-67. Am J Pathol. 1993. PMID: 8102029 Free PMC article. - The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes.
Paukkonen K, Naukkarinen A, Horsmanheimo M. Paukkonen K, et al. Arch Dermatol Res. 1995;287(2):165-70. doi: 10.1007/BF01262326. Arch Dermatol Res. 1995. PMID: 7763088 - Adhesion molecule mapping in normal human skin.
Konter U, Kellner I, Klein E, Kaufmann R, Mielke V, Sterry W. Konter U, et al. Arch Dermatol Res. 1989;281(7):454-62. doi: 10.1007/BF00510080. Arch Dermatol Res. 1989. PMID: 2692519
References
- J Invest Dermatol. 1984 Dec;83(6):416-20 - PubMed
- Arch Dermatol Res. 1985;277(5):352-8 - PubMed
- J Invest Dermatol. 1987 Mar;88(3):340-4 - PubMed
- Arch Dermatol Res. 1983;275(3):181-9 - PubMed
- Cell Immunol. 1975 Oct;19(2):245-61 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials